Thomas Lamy - Biosynex Deputy Director
| ALBIO Stock | EUR 2.88 0.06 2.13% |
Insider
Thomas Lamy is Deputy Director of Biosynex
| Phone | 33 3 88 78 78 87 |
| Web | https://www.biosynex.com |
Biosynex Management Efficiency
The company has return on total asset (ROA) of 0.4451 % which means that it generated a profit of $0.4451 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.8886 %, meaning that it generated $0.8886 on every $100 dollars invested by stockholders. Biosynex's management efficiency ratios could be used to measure how well Biosynex manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| David Franks | Novacyt | N/A | |
| Paul Oladimeji | Novacyt | N/A | |
| Khalil Filali | Intrasense | N/A | |
| Nicolas Reymond | Intrasense | 41 | |
| Jeremy Peyron | Intrasense | N/A | |
| Lionel Seltz | Intrasense | N/A | |
| FFPM MBA | Biophytis SA | 52 | |
| Grald Ulrich | Novacyt | N/A | |
| Herve MBA | Eurobio Scientific SA | 64 | |
| Denis Fortier | Eurobio Scientific SA | 55 | |
| Thomas Iff | Eurobio Scientific SA | N/A | |
| Bryan Close | Novacyt | N/A | |
| Philippe Rousseau | Biophytis SA | 52 | |
| JeanMichel Grandmougin | Eurobio Scientific SA | 62 | |
| Jacques Martin | Eurobio Scientific SA | N/A | |
| Benoit Canolle | Biophytis SA | 45 | |
| James McCarthy | Novacyt | 57 | |
| Teylan | Biophytis SA | N/A | |
Management Performance
| Return On Equity | 0.89 | |||
| Return On Asset | 0.45 |
Biosynex Management Team
Elected by the shareholders, the Biosynex's board of directors comprises two types of representatives: Biosynex inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Biosynex. The board's role is to monitor Biosynex's management team and ensure that shareholders' interests are well served. Biosynex's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Biosynex's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Thomas Lamy, Deputy Director | ||
| Thierry Paper, General Manager | ||
| Larry Abensur, Chairman CEO |
Biosynex Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Biosynex a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.89 | |||
| Return On Asset | 0.45 | |||
| Profit Margin | 0.21 % | |||
| Operating Margin | 0.30 % | |||
| Current Valuation | 91.77 M | |||
| Shares Outstanding | 10.25 M | |||
| Shares Owned By Insiders | 58.06 % | |||
| Shares Owned By Institutions | 1.58 % | |||
| Price To Earning | 48.98 X | |||
| Price To Book | 0.77 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Biosynex Stock Analysis
When running Biosynex's price analysis, check to measure Biosynex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biosynex is operating at the current time. Most of Biosynex's value examination focuses on studying past and present price action to predict the probability of Biosynex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biosynex's price. Additionally, you may evaluate how the addition of Biosynex to your portfolios can decrease your overall portfolio volatility.